|
depression |
15 |
|
anxiety |
13 |
|
covid-19 |
13 |
|
schizophrenia |
13 |
|
network analysis |
12 |
|
delusional disorder |
10 |
|
f-dopa |
10 |
|
first-episode psychosis |
10 |
|
negative symptoms |
10 |
|
positron emission tomography |
10 |
|
striatal dopamine capacity synthesis |
10 |
|
children & adolescents |
8 |
|
corpus striatum |
8 |
|
dopamine |
8 |
|
loneliness |
8 |
|
pharmacoepidemiology |
8 |
|
raclopride |
8 |
|
coping strategies |
7 |
|
correlates |
7 |
|
mental disorders |
7 |
|
post-traumatic stress disorder |
7 |
|
pre-existing mental disorders |
7 |
|
psychiatric patients |
7 |
|
psychopathology |
7 |
|
social support |
7 |
|
suicidal ideation |
7 |
|
survey |
7 |
|
coping styles |
6 |
|
late-life depression |
6 |
|
meta-analysis |
6 |
|
self-reported cognitive complaints |
6 |
|
systematic review |
6 |
|
traumatic stress symptoms |
6 |
|
advanced ovarian cancer |
5 |
|
aged |
5 |
|
cytoreduction |
5 |
|
dementia |
5 |
|
enhanced recovery |
5 |
|
insomnia |
5 |
|
oncology |
5 |
|
riot |
5 |
|
transcranial direct current stimulation |
5 |
|
anhedonia |
4 |
|
antidepressants |
4 |
|
benzodiazepines |
4 |
|
cognitive impairment |
4 |
|
depressive symptoms |
4 |
|
early detection |
4 |
|
electronic health record |
4 |
|
exercise |
4 |
|
gaze perception |
4 |
|
mentalisation |
4 |
|
older adults |
4 |
|
population-based |
4 |
|
prescribing trends |
4 |
|
prescription patters |
4 |
|
social cognition |
4 |
|
suicide |
4 |
|
tai chi |
4 |
|
temporal trends |
4 |
|
z-drugs |
4 |
|
brain stimulation |
3 |
|
cognitive dysfunction |
3 |
|
episodic |
3 |
|
learning |
3 |
|
memory |
3 |
|
mindfulness |
3 |
|
reward |
3 |
|
transcranial direct current stimulation (tdcs) |
3 |
|
transcranial magnetic stimulation |
3 |
|
adhd |
2 |
|
adolescents |
2 |
|
alzheimer's disease |
2 |
|
anodal transcranial |
2 |
|
augmentation therapy |
2 |
|
autism spectrum disorder |
2 |
|
brain |
2 |
|
carer |
2 |
|
cognitive function |
2 |
|
cortical thickness |
2 |
|
efficacy |
2 |
|
high-definition transcranial direct current stimulation |
2 |
|
magnetic resonance imaging |
2 |
|
major depressive disorder |
2 |
|
mild cognitive impairment |
2 |
|
neurocognitive disorder |
2 |
|
neuromodulation |
2 |
|
neuropsychological performance |
2 |
|
positive gain |
2 |
|
prefrontal cortex |
2 |
|
randomized clinical trial |
2 |
|
rct |
2 |
|
transcranial pulse stimulation |
2 |
|
working memory |
2 |
|
age at onset |
1 |
|
ai |
1 |
|
artificial intelligence |
1 |
|
asia pacific |
1 |
|
attention |
1 |
|
cognitive training |
1 |
|
delphi consensus |
1 |
|
dsm-5 |
1 |
|
elderly |
1 |
|
functional connectivity |
1 |
|
general public |
1 |
|
healthcare workers |
1 |
|
machine learning |
1 |
|
non-invasive brain stimulation |
1 |
|
noninvasive brain stimulation |
1 |
|
psychological impact |
1 |
|
psychosis |
1 |
|
psychosocial functioning |
1 |
|
randomised clinical trial |
1 |
|
randomized controlled trial |
1 |
|
sars |
1 |
|
vestibular stimulation |
1 |
